Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in Caco-2 cells

Sunhee Kim, Hyunhee Lee, Seulki Lee, Sang Kyoon Kim, Yong Kyu Lee, Bong Hyun Chung, Hyun Tae Moon, Youngro Byun

Research output: Contribution to journalArticle

Abstract

One approach for enhancing intestinal absorption of therapeutic peptides is chemical conjugation to bile acids. In this study, recombinant salmon calcitonin (sCT) was chemically modified by covalent attachment of deoxycholic acid (DOCA). Three different sCT-DOCA conjugates, namely, sCT-mono-DOCA, sCT-di-DOCA, and sCT-tri-DOCA, were prepared and characterized for their structural and biological properties. The permeability of these conjugates in the gastrointestinal tract was evaluated using Caco-2 cell monolayers to determine their potential as an oral dosage form. The conjugates were isolated by reversed-phase fast protein liquid chromatography (FPLC) and confirmed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Circular dichroism spectra in 50% trifluoroethanol aqueous condition showed the ordered secondary structure of sCT-DOCA. The biological activities of sCT-DOCA conjugates were evaluated by cyclic AMP assay using T-47D cells, and the mean EC50 values of sCT, sCT-mono-DOCA, and sCT-di-DOCA were 0.034, 0.076, and 0.46 nM, respectively. The transport experiments using the Caco-2 cell monolayer showed that the permeability of sCT-DOCA conjugates in buffer was not altered from the native sCT. However, the permeability of sCT-DOCA conjugates was increased up to 2.5 times that of the native sCT when sCT-DOCA was formulated in 1% dimethylsulfoxide (DMSO) solution. The conjugated DOCA of sCT-DOCA significantly enhanced the absorption of sCT-DOCA in the intestinal membrane when sCT-DOCA conjugates were completely solubilized by DMSO. In conclusion, this study proposes that therapeutic peptides that have poor absorption profiles could potentially be developed into orally active drugs by conjugation with DOCA in the formulation with appropriate solubilizing agents.

Original languageEnglish (US)
Pages (from-to)129-135
Number of pages7
JournalDrug Development Research
Volume64
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

Fingerprint

salmon calcitonin
Deoxycholic Acid
Caco-2 Cells
Calcitonin
Permeability

Keywords

  • Calcitonin
  • Chemical conjugate
  • Deoxycholic acid
  • DMSO
  • Oral delivery

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in Caco-2 cells. / Kim, Sunhee; Lee, Hyunhee; Lee, Seulki; Kim, Sang Kyoon; Lee, Yong Kyu; Chung, Bong Hyun; Moon, Hyun Tae; Byun, Youngro.

In: Drug Development Research, Vol. 64, No. 2, 02.2005, p. 129-135.

Research output: Contribution to journalArticle

Kim, Sunhee ; Lee, Hyunhee ; Lee, Seulki ; Kim, Sang Kyoon ; Lee, Yong Kyu ; Chung, Bong Hyun ; Moon, Hyun Tae ; Byun, Youngro. / Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in Caco-2 cells. In: Drug Development Research. 2005 ; Vol. 64, No. 2. pp. 129-135.
@article{f14eaefc3af94a2da28a010b71c64b42,
title = "Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in Caco-2 cells",
abstract = "One approach for enhancing intestinal absorption of therapeutic peptides is chemical conjugation to bile acids. In this study, recombinant salmon calcitonin (sCT) was chemically modified by covalent attachment of deoxycholic acid (DOCA). Three different sCT-DOCA conjugates, namely, sCT-mono-DOCA, sCT-di-DOCA, and sCT-tri-DOCA, were prepared and characterized for their structural and biological properties. The permeability of these conjugates in the gastrointestinal tract was evaluated using Caco-2 cell monolayers to determine their potential as an oral dosage form. The conjugates were isolated by reversed-phase fast protein liquid chromatography (FPLC) and confirmed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Circular dichroism spectra in 50{\%} trifluoroethanol aqueous condition showed the ordered secondary structure of sCT-DOCA. The biological activities of sCT-DOCA conjugates were evaluated by cyclic AMP assay using T-47D cells, and the mean EC50 values of sCT, sCT-mono-DOCA, and sCT-di-DOCA were 0.034, 0.076, and 0.46 nM, respectively. The transport experiments using the Caco-2 cell monolayer showed that the permeability of sCT-DOCA conjugates in buffer was not altered from the native sCT. However, the permeability of sCT-DOCA conjugates was increased up to 2.5 times that of the native sCT when sCT-DOCA was formulated in 1{\%} dimethylsulfoxide (DMSO) solution. The conjugated DOCA of sCT-DOCA significantly enhanced the absorption of sCT-DOCA in the intestinal membrane when sCT-DOCA conjugates were completely solubilized by DMSO. In conclusion, this study proposes that therapeutic peptides that have poor absorption profiles could potentially be developed into orally active drugs by conjugation with DOCA in the formulation with appropriate solubilizing agents.",
keywords = "Calcitonin, Chemical conjugate, Deoxycholic acid, DMSO, Oral delivery",
author = "Sunhee Kim and Hyunhee Lee and Seulki Lee and Kim, {Sang Kyoon} and Lee, {Yong Kyu} and Chung, {Bong Hyun} and Moon, {Hyun Tae} and Youngro Byun",
year = "2005",
month = "2",
doi = "10.1002/ddr.10423",
language = "English (US)",
volume = "64",
pages = "129--135",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Enhancing effect of chemically conjugated deoxycholic acid on permeability of calcitonin in Caco-2 cells

AU - Kim, Sunhee

AU - Lee, Hyunhee

AU - Lee, Seulki

AU - Kim, Sang Kyoon

AU - Lee, Yong Kyu

AU - Chung, Bong Hyun

AU - Moon, Hyun Tae

AU - Byun, Youngro

PY - 2005/2

Y1 - 2005/2

N2 - One approach for enhancing intestinal absorption of therapeutic peptides is chemical conjugation to bile acids. In this study, recombinant salmon calcitonin (sCT) was chemically modified by covalent attachment of deoxycholic acid (DOCA). Three different sCT-DOCA conjugates, namely, sCT-mono-DOCA, sCT-di-DOCA, and sCT-tri-DOCA, were prepared and characterized for their structural and biological properties. The permeability of these conjugates in the gastrointestinal tract was evaluated using Caco-2 cell monolayers to determine their potential as an oral dosage form. The conjugates were isolated by reversed-phase fast protein liquid chromatography (FPLC) and confirmed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Circular dichroism spectra in 50% trifluoroethanol aqueous condition showed the ordered secondary structure of sCT-DOCA. The biological activities of sCT-DOCA conjugates were evaluated by cyclic AMP assay using T-47D cells, and the mean EC50 values of sCT, sCT-mono-DOCA, and sCT-di-DOCA were 0.034, 0.076, and 0.46 nM, respectively. The transport experiments using the Caco-2 cell monolayer showed that the permeability of sCT-DOCA conjugates in buffer was not altered from the native sCT. However, the permeability of sCT-DOCA conjugates was increased up to 2.5 times that of the native sCT when sCT-DOCA was formulated in 1% dimethylsulfoxide (DMSO) solution. The conjugated DOCA of sCT-DOCA significantly enhanced the absorption of sCT-DOCA in the intestinal membrane when sCT-DOCA conjugates were completely solubilized by DMSO. In conclusion, this study proposes that therapeutic peptides that have poor absorption profiles could potentially be developed into orally active drugs by conjugation with DOCA in the formulation with appropriate solubilizing agents.

AB - One approach for enhancing intestinal absorption of therapeutic peptides is chemical conjugation to bile acids. In this study, recombinant salmon calcitonin (sCT) was chemically modified by covalent attachment of deoxycholic acid (DOCA). Three different sCT-DOCA conjugates, namely, sCT-mono-DOCA, sCT-di-DOCA, and sCT-tri-DOCA, were prepared and characterized for their structural and biological properties. The permeability of these conjugates in the gastrointestinal tract was evaluated using Caco-2 cell monolayers to determine their potential as an oral dosage form. The conjugates were isolated by reversed-phase fast protein liquid chromatography (FPLC) and confirmed by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Circular dichroism spectra in 50% trifluoroethanol aqueous condition showed the ordered secondary structure of sCT-DOCA. The biological activities of sCT-DOCA conjugates were evaluated by cyclic AMP assay using T-47D cells, and the mean EC50 values of sCT, sCT-mono-DOCA, and sCT-di-DOCA were 0.034, 0.076, and 0.46 nM, respectively. The transport experiments using the Caco-2 cell monolayer showed that the permeability of sCT-DOCA conjugates in buffer was not altered from the native sCT. However, the permeability of sCT-DOCA conjugates was increased up to 2.5 times that of the native sCT when sCT-DOCA was formulated in 1% dimethylsulfoxide (DMSO) solution. The conjugated DOCA of sCT-DOCA significantly enhanced the absorption of sCT-DOCA in the intestinal membrane when sCT-DOCA conjugates were completely solubilized by DMSO. In conclusion, this study proposes that therapeutic peptides that have poor absorption profiles could potentially be developed into orally active drugs by conjugation with DOCA in the formulation with appropriate solubilizing agents.

KW - Calcitonin

KW - Chemical conjugate

KW - Deoxycholic acid

KW - DMSO

KW - Oral delivery

UR - http://www.scopus.com/inward/record.url?scp=19944366963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944366963&partnerID=8YFLogxK

U2 - 10.1002/ddr.10423

DO - 10.1002/ddr.10423

M3 - Article

AN - SCOPUS:19944366963

VL - 64

SP - 129

EP - 135

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 2

ER -